Multiple System Atrophy Registry Study in China
Part of Brain & nervous system clinical trials.
This study is collecting information from patients with multiple system atrophy (a rare neurological condition affecting movement and body functions), Parkinson disease, and healthy volunteers to better understand these conditions. By participating, you help doctors learn more about how these diseases develop and progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You have been diagnosed with multiple system atrophy, Parkinson disease, or are a healthy volunteer without neurological disease
- You can provide your own informed consent or have a legal representative who can consent for you
- You are willing to undergo routine clinical evaluations and assessments
- You do not have other atypical parkinsonian syndromes (like progressive supranuclear palsy or corticobasal syndrome)
- You do not have parkinsonism caused by brain tumors, fluid on the brain, medication side effects, or other identifiable causes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug called ALT001 for people with multiple system atrophy (MSA). It aims to see if the drug is safe and may help slow the disease.
This study follows people with certain rare brain conditions that affect movement and thinking, such as multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration. It aims to learn more about how these conditions progress over time, which may help improve future care.
This study collects data from people with Parkinson's disease or multiple system atrophy (MSA) to better understand these conditions. You will have blood, saliva, optional spinal fluid tests, and brain scans (MRI, PET/SPECT).
This study uses brain scans and clinical check-ins to better diagnose and predict how Parkinson-related conditions may progress over time. It may help researchers find markers that explain why symptoms change, and could improve future care.
This study collects health information from adults with neurodegenerative diseases to help researchers learn more about these conditions and improve future care.
This study looks at how people with certain rare brain conditions (like progressive supranuclear palsy, corticobasal syndrome, or multiple system atrophy) use healthcare services and how their quality of life is affected. It may help doctors better support patients and their carers.
Hear when a new Multiple System Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.